CASI Pharmaceuticals, Inc (DE) Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$19.5M, a 249% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$41M, a 11.9% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2022 was -$41M, a 11.9% decline from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2021 was -$36.7M, a 24.1% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2020 was -$48.3M, a 4.9% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$41M -$19.5M -$13.9M -249% Oct 1, 2022 Dec 31, 2022 20-F 2023-04-26
Q3 2022 -$27.1M -$5.2M +$5.02M +49.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$32.1M -$7.68M -$734K -10.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2022 -$31.4M -$8.6M +$5.29M +38.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-14
Q4 2021 -$36.7M -$5.6M +$8.6M +60.6% Oct 1, 2021 Dec 31, 2021 20-F 2023-04-26
Q3 2021 -$45.3M -$10.2M +$6.73M +39.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$52M -$6.95M +$1.75M +20.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$53.7M -$13.9M -$5.44M -64.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$48.3M -$14.2M -$1.71M -13.7% Oct 1, 2020 Dec 31, 2020 20-F 2023-04-26
Q3 2020 -$46.6M -$17M -$7.06M -71.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$39.5M -$8.69M +$6.78M +43.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$46.3M -$8.44M -$264K -3.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$46M -$12.5M -$3.23M -34.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$42.8M -$9.89M -$1.14M -13% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$41.7M -$15.5M -$9.61M -164% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$32.1M -$8.18M -$4.59M -128% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$27.5M -$9.26M -$4.22M -83.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$23.3M -$8.76M -$7.14M -443% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$16.1M -$5.86M -$3.45M -143% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$12.7M -$3.59M -$1.89M -111% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$10.8M -$5.05M -$2.37M -88.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.4M -$1.61M +$80K +4.72% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$8.48M -$2.41M +$883K +26.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$9.36M -$1.7M +$94.2K +5.25% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$9.45M -$2.67M -$971K -57% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$8.48M -$1.69M -$88.6K -5.52% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.39M -$3.29M -$1.2M -57.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.2M -$1.79M +$8.99K +0.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$7.21M -$1.7M -$106K -6.64% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$7.1M -$1.6M +$19.9M +92.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$27M -$2.1M -$479K -29.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$26.6M -$1.8M -$352K -24.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$26.2M -$1.6M -$288K -22% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$25.9M -$21.5M -$20.1M -1393% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$5.82M -$1.62M +$236K +12.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$6.05M -$1.45M -$315K -27.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$5.74M -$1.31M -$948K -263% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$4.79M -$1.44M -$254K -21.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.54M -$1.85M +$8.61M +82.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$13.1M -$1.14M +$1.4M +55.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$14.5M -$360K -$1.36M -136% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 -$13.2M -$1.19M +$121K +9.22% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$13.3M -$10.5M -$8.8M -531% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.5M -$2.53M +$62.5K +2.41% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.56M $1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-21
Q3 2011 -$1.31M +$787K +37.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.66M +$3.29M +66.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$2.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$2.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.94M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.